MedPath

Reducing Hypoglycemia Fear in Parents of Young Children With Type 1 Diabetes

Not Applicable
Completed
Conditions
Parents
Interventions
Behavioral: REDCHiP
Registration Number
NCT03879642
Lead Sponsor
University of Kansas Medical Center
Brief Summary

Pilot of a novel video-based telemedicine intervention to reduce fear of hypoglycemia in parents of young children with type 1 diabetes.

Detailed Description

This was a two group randomized controlled study using a wait-list control design. All participating parents had the opportunity to receive 10 video-based telemedicine sessions administered over 13 weeks. Study assessments took place at baseline, post-treatment, and 3 month followup. Study outcomes included parent reported hypoglycemia fear, parenting stress, diabetes distress, and child glycated hemoglobin.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
43
Inclusion Criteria
  • Parents of children, between 1-6 years old, with type 1 diabetes for at least 6 months, on either multiple daily injections or an insulin pump, and parents speak English
Exclusion Criteria
  • Families of children who are older than 6 years-old and or do not have type 1 diabetes; children follow a conventional insulin regimen

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
REDCHiPREDCHiP10 week video-based telemedicine intervention to reduce parents hypoglycemia fear
Primary Outcome Measures
NameTimeMethod
Hypoglycemia Fear Surveyabsolute value at post-treatment (week 14)

Hypoglycemia Fear Survey-Parents of Young Children. This is a measure of parents' perceived hypoglycemia fear. Higher scores suggest greater fear (worse outcome). Total possible range: 26-130.

Secondary Outcome Measures
NameTimeMethod
Child Hemoglobin A1cabsolute value at post-treatment (week 14)

Child hemoglobin A1c- biological marker of glycemic control

© Copyright 2025. All Rights Reserved by MedPath